The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Expression of novel immunotherapeutic targets in triple-negative breast cancer.
Gargi Dan Basu
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Anatole Ghazalpour
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Zoran Gatalica
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Karen S. Anderson
No relevant relationships to disclose
Ann E. McCullough
No relevant relationships to disclose
David B. Spetzer
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Barbara A. Pockaj
No relevant relationships to disclose